ArticleScientific reports2025
Integrating visceral protein ratios and mid-arm circumference predicts survival and malnutrition in gastric cancer.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prognostic Role of Nutritional and Inflammatory Indices in Predicting Adverse Clinical Outcomes in Unplanned Hospitalized Oncology Patients.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Gastric cancer, a leading cause of cancer-related mortality globally, lacks robust biomarkers for comprehensive prognosis. Accordingly, we examined the prognostic utility of combining the albumin-prealbumin-globulin ratio (APGR) with mid-arm circumference (MAC) for assessing survival, malnutrition, and metastasis in gastric cancer. A multicenter cohort comprising 1,803 patients with gastric cancer was categorized into three groups based on APGR and MAC values: normal, moderate-risk, and high-risk grades. Associations with overall survival (OS), malnutrition, and metastasis were evaluated using Cox proportional hazard regression and logistic regression analyses. Normal grade patients exhibited the highest OS (68.6%), followed by those with medium-risk (53.9%) and high-risk (39.9%) grades (P < 0.001). Normal grade individuals had a 50% lower mortality risk (Hazard ratio [HR], 0.500, 95% confidence interval [CI]: 0.411-0.609; P < 0.001) than high-risk grade patients, with moderate-risk grade patients demonstrating a 27.2% reduction (HR, 0.728, 95% CI: 0.617-0.860; P < 0.001). Normal grade independently predicted a reduced risk of malnutrition (Odds ratio [OR], 0.249, 95% CI: 0.188-0.329; P < 0.001) and lower odds of metastasis (OR, 0.477, 95% CI: 0.324-0.701; P < 0.001). The composite index exhibited better discriminative ability (C-index = 0.595) than APGR (0.572) and MAC (0.558). Subgroup analyses revealed excellent prognostic discriminative ability across all TNM stages and sex subgroups, with sensitivity analysis, excluding early mortality, confirming the robustness of these findings. By integrating serological and anthropometric parameters, this composite index offers a clinically actionable framework for risk stratification in gastric cancer, improving the prognostic accuracy for survival, malnutrition, and metastasis. Its adoption can guide personalized interventions and improve clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.